文献速递头颈部肿瘤放疗放疗物理与技术

探讨中性粒细胞与淋巴细胞比值及血液生化指标在碳离子放疗头颈部腺样囊性癌中的作用

Exploring the role of neutrophil-to-lymphocyte ratio and blood chemistry in head and neck adenoid cystic carcinomas treated with carbon ion radiotherapy.
PubMed 文献 · Radiother Oncol · 2022-10-31

该回顾性研究纳入49例连续接受碳离子放疗的头颈部腺样囊性癌患者,分析基线中性粒细胞与淋巴细胞比值(NLR)及血液生化指标的预后意义。血红蛋白≤14 g/dL患者DFS、MFS、OS显著更好。

要点

  • 血红蛋白≤14 g/dL患者DFS、MFS、OS显著优于血红蛋白>14 g/dL者。

核心结论

  • 治疗前NLR和血红蛋白值似乎是头颈部腺样囊性癌患者临床结局的独立预后因素。
  • 若其作用在更大规模的前瞻性队列中得到验证,可能对接受碳离子放疗患者的治疗前风险分层有价值。

研究设计与样本

  • 回顾性研究,纳入49例连续接受碳离子放疗的头颈部腺样囊性癌患者。
  • 采用单因素和多因素Cox比例风险回归分析,探讨NLR及其他血液生物标志物值与无病生存(DFS)、局部控制(LC)、无转移生存(MFS)和总生存(OS)的潜在关联。

主要发现

  • 血红蛋白≤14 g/dL患者DFS、MFS和OS显著更好。

临床怎么用

  • 原文未据此给出推荐。
  • 作者认为,若治疗前NLR和血红蛋白值的作用在更大规模的前瞻性队列中得到验证,可能对接受碳离子放疗患者的治疗前风险分层有价值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: In recent years, there is an emerging interest in the prognostic role of chemistry blood biomarkers in oncological patients but their role in adenoid cystic carcinomas (ACCs) is still unknown. This study aims to assess the prognostic significance of baseline neutrophil-to-lymphocyte ratio (NLR) and blood chemistry in a series of head and neck ACC patients treated with carbon ion radiotherapy (CIRT). MATERIAL AND METHODS: We retrospectively retrieved the data of 49 consecutive head and neck ACC patients treated with CIRT. Univariable and multivariable Cox proportional hazard regression (Cox-ph) analyses were performed to look for a potential association of NLR, and other blood biomarker values, with disease-free survival (DFS), Local Control (LC), Metastasis Free Survival (MFS) and overall survival (OS). RESULTS: No significant association between NLR > 2,5 and DFS, LC, MFS and OS was found with univariable analysis although a trend was reported for DFS (Hazard ratio [HR]: 2,10, 95 % CI: 0,85 - 5,08, p-value = 0,11). Patients with hemoglobin (hb) ≤ 14 g/dL showed significantly better DFS, MFS and OS. Multivariable regression Cox-ph analysis for DFS, adjusted for margin status, clinical target volume and Absolute Number of Monocytes, reported the following statistically significant HRs, for both NLR > 2,5 and hb > 14 g/dL respectively: 4,850 (95 % CI = 1,408 - 16,701, p = 0,012) and 3,032 (95 % CI = 1,095 - 8,393, p = 0,033). Moreover, hb > 14 with HR = 3,69 (95 % CI: 1,23 - 11,07, p-value = 0,02), was a negative independent prognostic predictor for MFS. CONCLUSIONS: Pre-treatment NLR and hb values seem to be independent prognostic predictor for clinical outcomes in head and neck ACC patients. If their role will be validated in a larger prospective cohort, they might be worthwhile for a pre-treatment risk stratification in patients treated with CIRT.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Barcellini A, Fontana G, Filippini DM, et al. Exploring the role of neutrophil-to-lymphocyte ratio and blood chemistry in head and neck adenoid cystic carcinomas treated with carbon ion radiotherapy. Radiother Oncol. 2022. PMID: 36328091. doi:10.1016/j.radonc.2022.10.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。